285 related articles for article (PubMed ID: 17995595)
1. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins.
Girennavar B; Jayaprakasha GK; Patil BS
J Food Sci; 2007 Oct; 72(8):C417-21. PubMed ID: 17995595
[TBL] [Abstract][Full Text] [Related]
2. Furocoumarins from grapefruit juice and their effect on human CYP 3A4 and CYP 1B1 isoenzymes.
Girennavar B; Poulose SM; Jayaprakasha GK; Bhat NG; Patil BS
Bioorg Med Chem; 2006 Apr; 14(8):2606-12. PubMed ID: 16338240
[TBL] [Abstract][Full Text] [Related]
3. Radical scavenging and cytochrome P450 3A4 inhibitory activity of bergaptol and geranylcoumarin from grapefruit.
Girennavar B; Jayaprakasha GK; Jadegoud Y; Nagana Gowda GA; Patil BS
Bioorg Med Chem; 2007 Jun; 15(11):3684-91. PubMed ID: 17400460
[TBL] [Abstract][Full Text] [Related]
4. Major furocoumarins in grapefruit juice II: phototoxicity, photogenotoxicity, and inhibitory potency vs. cytochrome P450 3A4 activity.
Messer A; Raquet N; Lohr C; Schrenk D
Food Chem Toxicol; 2012 Mar; 50(3-4):756-60. PubMed ID: 22155270
[TBL] [Abstract][Full Text] [Related]
5. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
[TBL] [Abstract][Full Text] [Related]
6. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
Bailey DG; Dresser GK; Bend JR
Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
[TBL] [Abstract][Full Text] [Related]
7. Screening of furanocoumarin derivatives as cytochrome P450 3A4 inhibitors in citrus.
Masuda M; Watanabe S; Tanaka M; Tanaka A; Araki H
J Clin Pharm Ther; 2018 Feb; 43(1):15-20. PubMed ID: 28749005
[TBL] [Abstract][Full Text] [Related]
8. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.
Greenblatt DJ; von Moltke LL; Harmatz JS; Chen G; Weemhoff JL; Jen C; Kelley CJ; LeDuc BW; Zinny MA
Clin Pharmacol Ther; 2003 Aug; 74(2):121-9. PubMed ID: 12891222
[TBL] [Abstract][Full Text] [Related]
9. Processing grapefruit juice with γ-cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity.
Yamasaki K; Iohara D; Oyama Y; Nishizaki N; Kawazu S; Nishi K; Kadowaki D; Taguchi K; Otagiri M; Seo H
J Pharm Pharmacol; 2020 Mar; 72(3):356-363. PubMed ID: 31828807
[TBL] [Abstract][Full Text] [Related]
10. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.
Malhotra S; Bailey DG; Paine MF; Watkins PB
Clin Pharmacol Ther; 2001 Jan; 69(1):14-23. PubMed ID: 11180034
[TBL] [Abstract][Full Text] [Related]
11. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.
Kakar SM; Paine MF; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411
[TBL] [Abstract][Full Text] [Related]
12. Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition.
Paine MF; Criss AB; Watkins PB
J Pharmacol Exp Ther; 2005 Mar; 312(3):1151-60. PubMed ID: 15485894
[TBL] [Abstract][Full Text] [Related]
13. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
Edwards DJ; Bellevue FH; Woster PM
Drug Metab Dispos; 1996 Dec; 24(12):1287-90. PubMed ID: 8971132
[TBL] [Abstract][Full Text] [Related]
14. Major furocoumarins in grapefruit juice I: levels and urinary metabolite(s).
Messer A; Nieborowski A; Strasser C; Lohr C; Schrenk D
Food Chem Toxicol; 2011 Dec; 49(12):3224-31. PubMed ID: 21945416
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CYP3A4 by 6',7'-dihydroxybergamottin in human CYP3A4 over-expressed hepG2 cells.
Araki N; Tsuruoka S; Hasegawa G; Yanagihara H; Omasa T; Enosawa S; Yamazoe Y; Fujimura A
J Pharm Pharmacol; 2012 Dec; 64(12):1715-21. PubMed ID: 23146034
[TBL] [Abstract][Full Text] [Related]
16. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.
Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P
Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255
[TBL] [Abstract][Full Text] [Related]
17. Dihydroxybergamottin caproate as a potent and stable CYP3A4 inhibitor.
Ohta T; Nagahashi M; Hosoi S; Tsukamoto S
Bioorg Med Chem; 2002 Apr; 10(4):969-73. PubMed ID: 11836106
[TBL] [Abstract][Full Text] [Related]
18. Effect of maturity, processing, and storage on the furanocoumarin composition of grapefruit and grapefruit juice.
Cancalon PF; Barros SM; Haun C; Widmer WW
J Food Sci; 2011 May; 76(4):C543-8. PubMed ID: 22417333
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.
Schmiedlin-Ren P; Edwards DJ; Fitzsimmons ME; He K; Lown KS; Woster PM; Rahman A; Thummel KE; Fisher JM; Hollenberg PF; Watkins PB
Drug Metab Dispos; 1997 Nov; 25(11):1228-33. PubMed ID: 9351897
[TBL] [Abstract][Full Text] [Related]
20. Synthetic models related to furanocoumarin-CYP 3A4 interactions. comparison of furanocoumarin, coumarin, and benzofuran dimers as potent inhibitors of CYP3A4 activity.
Oda K; Yamaguchi Y; Yoshimura T; Wada K; Nishizono N
Chem Pharm Bull (Tokyo); 2007 Sep; 55(9):1419-21. PubMed ID: 17827777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
